Arrestins in Actin Reorganization and Cell Migration - Progress in Molecular Biology and Translational Science - page 215

17. Ge L, Ly Y, Hollenberg M, DeFea K. A beta-arrestin-dependent scaffold is associated
with prolonged MAPK activation in pseudopodia during protease-activated receptor-
2-induced chemotaxis. J Biol Chem . 2003;278:34418 - 34426.
18. Hall A. Rho GTPases and the actin cytoskeleton. Science . 1998;279:509 - 514.
19. Barnes WG, Reiter E, Violin JD, Ren X-R, Milligan G, Lefkowitz RJ. b -Arrestin 1 and
G a q/11 coordinately activate RhoA and stress fiber formation following receptor stim-
ulation. J Biol Chem . 2005;280:8041 - 8050.
20. Bhattacharya M, Wang J, Ribeiro FM, et al. Analysis of a missense variant of the human
N-formyl peptide receptor that is associated with agonist-independent [beta]-arrestin
association and indices of inflammation. Pharmacogenomics J . 2006;7:190 - 199.
21. Bhattacharya M, Anborgh PH, Babwah AV, et al. [beta]-Arrestins regulate a Ral-
GDS-Ral effector pathway that mediates cytoskeletal reorganization. Nat Cell Biol .
2002;4:547 - 555.
22. Gong K, Li Z, Xu M, Du J, Lv Z, Zhang Y. A novel protein kinase A-independent,
beta-arrestin-1-dependent signaling pathway for p38 mitogen-activated protein kinase
activation by beta2-adrenergic receptors. J Biol Chem . 2008;283:29028 - 29036.
23. Mythreye K, Blobe GC. The type III TGFbeta receptor regulates directional migration:
new tricks for an old dog. Cell Cycle . 2009;8:3069 - 3070.
24. Mythreye K, Blobe GC. The type III TGF-beta receptor regulates epithelial and cancer
cell migration through beta-arrestin2-mediated activation of Cdc42. Proc Natl Acad Sci
USA . 2009;106:8221- 8226.
25. Anthony DF, Sin YY, Vadrevu S, et al. {beta}-Arrestin 1 inhibits the GTPase-activating
protein function of ARHGAP21, promoting activation of RhoA following angiotensin
II type 1A receptor stimulation. Mol Cell Biol . 2011;31:1066 - 1075.
26. Wang P, DeFea KA. Protease-activated receptor-2 simultaneously directs beta-arrestin-1-
dependent inhibition and Galphaq-dependent activation of phosphatidylinositol 3-kinase.
Biochemistry . 2006;45:9374 - 9385.
27. Povsic TJ, Kohout TA, Lefkowitz RJ. Beta-arrestin1 mediates insulin-like growth factor
1 (IGF-1) activation of phosphatidylinositol 3-kinase (PI3K) and anti-apoptosis. J Biol
Chem . 2003;278:51334 - 51339.
28. Li TT, Alemayehu M, Aziziyeh AI, et al. Beta-arrestin/Ral signaling regulates
lysophosphatidic acid-mediated migration and invasion of human breast tumor cells.
Mol Cancer Res . 2009;7:1064 - 1077.
29. Ohta Y, Suzuki N, Nakamura S, Hartwig JH, Stossel TP. The small GTPase RalA targets
filamin to induce filopodia. Proc Natl Acad Sci USA . 1999;96:2122 - 2128.
30. Decaillot FM, Kazmi MA, Lin Y, Ray-Saha S, Sakmar TP, Sachdev P. CXCR7/
CXCR4 heterodimer constitutively recruits b -arrestin to enhance cell migration.

J Biol Chem . 2011;286:32188- 32197.
31. Christensen GL, Kelstrup CD, Lyngsø C, et al. Quantitative phosphoproteomics dissec-
tion of 7TM receptor signaling using full and biased agonists. Mol Cell Proteomics .
2010;9:1540 - 1553.
32. Campellone KG, Welch MD. A nucleator arms race: cellular control of actin assembly.
Nat Rev Mol Cell Biol . 2010;11:237 - 251.
33. Firat-Karalar EN, Welch MD. New mechanisms and functions of actin nucleation. Curr
Opin Cell Biol . 2011;23:4 - 13.
34. Nakanishi O, Suetsugu S, Yamazaki D, Takenawa T. Effect of WAVE2 phosphory-
lation on activation of the Arp2/3 complex. J Biochem . 2007;141:319 - 325.
35. Mendoza Michelle C, Er EE, Zhang W, et al. ERK-MAPK drives lamellipodia protru-
sion by activating the WAVE2 regulatory complex. Mol Cell . 2011;41:661 - 671.
36. Luttrell LM, Gesty-Palmer D. Beyond desensitization: physiological relevance of
arrestin-dependent signaling. Pharm Rev . 2010;62:305 - 330.